GANGLIONEUROBLASTOMA, NODULAR
Clinical trials for GANGLIONEUROBLASTOMA, NODULAR explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROBLASTOMA, NODULAR trials appear
Sign up with your email to follow new studies for GANGLIONEUROBLASTOMA, NODULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new therapy combo targets tough childhood cancer
Disease control Recruiting nowThis study tests whether adding a radioactive drug (131I-MIBG) or a targeted pill (lorlatinib) to standard intensive therapy helps children with high-risk neuroblastoma live longer without the cancer coming back. About 750 children and young adults (ages 1 to 30) with newly diagn…
Matched conditions: GANGLIONEUROBLASTOMA, NODULAR
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Hope for kids with rare cancer: new drug combo trial launches
Disease control Recruiting nowThis study tests whether adding the drug dinutuximab to standard chemotherapy and other treatments helps children with high-risk neuroblastoma live longer without the cancer coming back. About 478 children and young adults up to age 30 with newly diagnosed high-risk neuroblastoma…
Matched conditions: GANGLIONEUROBLASTOMA, NODULAR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC